Skip to main content
Thursday
December 07, 2023
Sign In
Subscribe
Home
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
World+Biz
Sports
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Epaper
GOVT. Ad
More
Subscribe
Videos
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
COVID-19
Long Read
Interviews
Offbeat
Tech
Magazine
বাংলা
THURSDAY,
DECEMBER 07, 2023
Bharat Biotech
Coronavirus chronicle
India launches world’s 1st intranasal Covid vaccine
Coronavirus chronicle
‘Big boost’: Bharat Biotech’s nasal Covid-19 vaccine gets green light
Coronavirus chronicle
Indian drug regulator okays Covaxin for 6-12 year olds, Corbevax for 5-12 bracket
Coronavirus chronicle
India gives nod to Bharat Biotech for intranasal Covid booster doses
Coronavirus chronicle
India's Bharat Biotech says Covaxin booster shot neutralises Omicron
Coronavirus chronicle
Bharat Biotech gets approval to test nasal Covid-19 shot as booster - report
Coronavirus chronicle
Bharat Biotech to produce 1 billion nasal vaccines in 2022
Coronavirus chronicle
Bharat's Covid-19 shot 50% effective at height of India infections - small study
Coronavirus chronicle
India recommends homemade Covid-19 vaccine for kids aged 2 and above
World+Biz
Bharat Biotech says it received no advance payment from Brazil govt for Covaxin
Coronavirus chronicle
Covaxin manufacturing to vaccination takes 4 months, says Bharat Biotech
Coronavirus chronicle
Bharat Biotech submits ‘90% of documents’ for WHO nod
Coronavirus chronicle
India's Bharat Biotech to produce additional 200 mln Covid-19 vaccine doses per year
Show More